Medicare Coverage For Alzheimer’s Drugs: CMS Declines To Revise Restrictions For Class

Medicare coverage restrictions are more likely to be reconsidered on a case-by-case basis as drugs in the class obtain traditional US Food and Drug Administration approvals in the coming months.